Testosterone clinical trials
28 active trials name this biomarker in their eligibility criteria. Describe your situation to see which ones you may be eligible for.
- Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer
- Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial
- Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
- Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients
- Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
- ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
- The University of Miami Adapt (UAdapt) Trial
- Testosterone Treatment in Men with Chronic Kidney Disease
- A Clinical Trial Evaluating the Efficacy and Safety of Leflutrozole on Testicular Function
- Axelopran in Advanced Cancers
- The Impact of Dietary Pattern on Erectile Function
- A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer
- An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial
- Reproductive Axis Maturation in the Early Post-Menarchal Years
- Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord Injury
- The REgistry of Very Early Estrogen and AnovuLation
- Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?
- Role of Race in Nutritional Approach in Men on ADT
- Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
- Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
- Adaptions and Resiliency to Multi-Stressor OpeRations
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
- An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone and HSDD
- Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis
- The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System
- Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
Guides for people searching for a trial
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that name “Testosterone” in their eligibility criteria, at any level. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.